Patents by Inventor Noriko Satake

Noriko Satake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10509036
    Abstract: Provided herein are methods for selecting/identifying and/or isolating cancer stem cells from a biological sample or a cell culture sample using a fluorescent glucose analog. Also provided herein are methods for selecting/identifying and/or isolating leukemia stem cells and subpopulations thereof. The present invention is based, in part, on the discovery that cancer stem cells can be selected/identified based upon a lower level of fluorescence of the fluorescent glucose analog compared to non-cancer stem cells and that specific genes are differentially expressed in leukemia stem cells compared to non-leukemia stem cells.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: December 17, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Noriko Satake, Nitin Nitin
  • Publication number: 20180011100
    Abstract: Provided herein are methods for selecting/identifying and/or isolating cancer stem cells from a biological sample or a cell culture sample using a fluorescent glucose analog. Also provided herein are methods for selecting/identifying and/or isolating leukemia stem cells and subpopulations thereof. The present invention is based, in part, on the discovery that cancer stem cells can be selected/identified based upon a lower level of fluorescence of the fluorescent glucose analog compared to non-cancer stem cells and that specific genes are differentially expressed in leukemia stem cells compared to non-leukemia stem cells.
    Type: Application
    Filed: May 4, 2017
    Publication date: January 11, 2018
    Applicant: The Regents of the University of California
    Inventors: Noriko Satake, Nitin Nitin
  • Patent number: 9714288
    Abstract: The present disclosure provides compounds comprising modified oligonucleotides and anti-CD22 antibodies. Certain such modified oligonucleotides conjugated to anti-CD22 antibodies are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: July 25, 2017
    Assignees: The Regents of the University of California, Ionis Pharmaceuticals, Inc.
    Inventors: Michael Oestergaard, Punit P. Seth, Shuling Guo, Noriko Satake, Nitin Nitin, Joseph M. Tuscano
  • Publication number: 20160090598
    Abstract: The present disclosure provides compounds comprising modified oligonucleotides and anti-CD22 antibodies. Certain such modified oligonucleotides conjugated to anti-CD22 antibodies are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.
    Type: Application
    Filed: September 30, 2015
    Publication date: March 31, 2016
    Inventors: Michael Oestergaard, Punit P. Seth, Shuling Guo, Noriko Satake, Nitin Nitin, Joseph M. Tuscano
  • Patent number: D279104
    Type: Grant
    Filed: August 10, 1983
    Date of Patent: June 4, 1985
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D279188
    Type: Grant
    Filed: November 29, 1983
    Date of Patent: June 11, 1985
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D284202
    Type: Grant
    Filed: April 19, 1984
    Date of Patent: June 10, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D284288
    Type: Grant
    Filed: April 19, 1984
    Date of Patent: June 17, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D285575
    Type: Grant
    Filed: November 19, 1984
    Date of Patent: September 9, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D285806
    Type: Grant
    Filed: June 15, 1984
    Date of Patent: September 23, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D286544
    Type: Grant
    Filed: September 25, 1984
    Date of Patent: November 4, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D287024
    Type: Grant
    Filed: June 15, 1984
    Date of Patent: December 2, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D287253
    Type: Grant
    Filed: September 25, 1984
    Date of Patent: December 16, 1986
    Assignee: Sharp Corporation
    Inventor: Noriko Satake
  • Patent number: D290374
    Type: Grant
    Filed: May 3, 1985
    Date of Patent: June 16, 1987
    Assignee: Sharp Corporation
    Inventors: Takahisa Yubisui, Noriko Satake
  • Patent number: D291325
    Type: Grant
    Filed: May 3, 1985
    Date of Patent: August 11, 1987
    Assignee: Sharp Corporation
    Inventors: Takahisa Yubisui, Noriko Satake
  • Patent number: D294280
    Type: Grant
    Filed: November 27, 1985
    Date of Patent: February 16, 1988
    Assignee: Sharp Corporation
    Inventors: Takahisa Yubisui, Hiroshi Sakaguchi, Noriko Satake
  • Patent number: D303677
    Type: Grant
    Filed: April 1, 1986
    Date of Patent: September 26, 1989
    Assignee: Sharp Kabushiki Kaisha
    Inventors: Takahisa Yubisui, Hiroshi Sakaguchi, Noriko Satake